Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20220,818,1.13 [0.97-1.32],0.1073038904770713
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19591,241,1.31 [0.99-1.72],0.0573604468834682
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22425,143,1.18 [0.83-1.68],0.3625861721718768
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15093,811,1.29 [1.11-1.51],0.0012383001190094
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22385,103,1.16 [0.77-1.75],0.4860273962391663
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20308,90,1.32 [0.84-2.07],0.2259124863615429
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23433,102,1.18 [0.78-1.78],0.4271793523302053
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23445,70,1.20 [0.73-1.96],0.4735082391114661
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19880,52,1.57 [0.87-2.84],0.1308758391057394
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22439,119,1.10 [0.74-1.61],0.6434200781371643
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22403,83,1.31 [0.83-2.06],0.2467532148134856
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23522,59,0.69 [0.39-1.22],0.1981387640720111
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23542,63,1.34 [0.78-2.28],0.2856339571764685
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23535,56,1.16 [0.66-2.06],0.6024163703209564
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Mycoses,23203,42,2.18 [1.19-3.97],0.0113876303232123
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22270,388,1.24 [1.00-1.54],0.0489751158286636
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22032,150,1.21 [0.86-1.72],0.2732949492176039
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22146,264,1.29 [1.00-1.67],0.0523201064260403
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18383,81,0.73 [0.46-1.18],0.2021494647449967
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18350,48,0.95 [0.51-1.80],0.8808123495825267
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18571,269,1.06 [0.81-1.38],0.6716699678147802
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18579,277,1.04 [0.80-1.34],0.7930935600708237
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18537,235,1.34 [1.02-1.76],0.0363212974513333
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18355,53,1.44 [0.81-2.56],0.2090623120591417
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20892,564,1.77 [1.48-2.11],2.2787675761498467e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22031,375,1.03 [0.83-1.28],0.7694444291616647
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22937,128,0.96 [0.66-1.40],0.8397157853235055
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23584,131,1.14 [0.80-1.64],0.4623918294191249
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Rectum,23249,75,1.15 [0.71-1.86],0.5623392623410242
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23601,66,1.21 [0.73-2.01],0.4637927461587382
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign neoplasm: Stomach,23648,49,0.86 [0.47-1.59],0.6300358473794401
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm,23329,317,0.93 [0.73-1.19],0.5697022380222698
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23614,107,0.95 [0.63-1.44],0.8249937586400599
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23620,74,0.94 [0.58-1.55],0.8201626242649478
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23565,34,1.14 [0.55-2.36],0.7330315381675887
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,"Haemangioma, any site",23567,34,1.14 [0.55-2.36],0.7327927467237687
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi,23497,131,0.90 [0.61-1.31],0.5744381579123665
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23628,55,1.15 [0.64-2.05],0.6389606528002596
AGER,Advanced glycosylation end product-specific receptor,Chapter II Neoplasms,Other benign neoplasms of skin,23525,134,1.14 [0.79-1.65],0.4935148186560546
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22449,124,1.50 [1.04-2.16],0.029834095900773
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22070,258,2.07 [1.61-2.67],1.3320768012047842e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22070,258,2.07 [1.61-2.67],1.3320768012047842e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19849,510,1.47 [1.22-1.78],6.763794866788066e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23120,39,1.00 [0.50-1.98],0.9915807894051464
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23388,62,0.80 [0.47-1.39],0.4325848694149485
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18501,1439,1.30 [1.15-1.46],2.1064119168211845e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22933,179,1.26 [0.93-1.73],0.1394707270777959
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20864,146,1.81 [1.30-2.52],0.0004315056669797
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22279,163,1.10 [0.80-1.53],0.5556883033844008
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20849,131,1.85 [1.30-2.61],0.000538527680943
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21415,697,1.41 [1.21-1.66],2.136896544309677e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21390,672,1.37 [1.17-1.61],0.0001455435067057
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21895,174,1.12 [0.80-1.58],0.4993999533407814
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21895,173,1.15 [0.82-1.62],0.4185275888255996
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18346,1284,1.29 [1.14-1.47],6.529855045693089e-05
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17245,183,1.55 [1.14-2.12],0.0053965101629122
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,18244,1182,1.27 [1.12-1.45],0.0003284389222648
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17113,51,1.64 [0.90-2.96],0.1041211069390995
AGER,Advanced glycosylation end product-specific receptor,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17160,98,1.78 [1.17-2.71],0.0070706645416759
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Any mental disorder,20064,685,1.15 [0.97-1.36],0.0970284910765675
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19716,337,0.92 [0.72-1.17],0.4826837432532008
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23083,260,0.91 [0.70-1.19],0.48742901043442
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23171,199,0.91 [0.68-1.23],0.5531603436129173
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21549,78,0.93 [0.57-1.52],0.7820789483300726
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23503,78,0.92 [0.57-1.49],0.7425257538982541
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19457,78,0.95 [0.58-1.55],0.8302284038820503
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Alcohol dependence,21586,115,0.93 [0.62-1.39],0.7276803576845252
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Smoking dependency,21576,82,0.90 [0.57-1.44],0.6608353289656664
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19446,67,1.60 [0.96-2.67],0.0734976530331543
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19648,269,1.32 [1.02-1.71],0.0375483398650256
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Depression,22460,229,1.35 [1.02-1.78],0.0340624392943009
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Depression or dysthymia,19354,195,1.21 [0.89-1.65],0.219657017514087
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19482,103,1.30 [0.86-1.97],0.2179840792884845
AGER,Advanced glycosylation end product-specific receptor,Chapter V Mental and behavioural disorders,Other anxiety disorders,22657,55,1.28 [0.73-2.23],0.3927753725452211
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Neurological diseases,20007,1307,1.13 [1.00-1.28],0.0517238258966138
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18012,84,0.94 [0.58-1.53],0.8106733015287316
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23546,59,1.06 [0.60-1.87],0.8457596281259769
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22306,534,1.05 [0.87-1.26],0.6048037300794995
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Epilepsy,21935,163,0.75 [0.53-1.05],0.0950283555210454
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Migraine,21805,33,1.52 [0.73-3.14],0.259710256219406
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23488,27,2.12 [0.99-4.55],0.0542535783247943
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22682,98,nan [nan-nan],
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other sleep disorders,22006,234,1.01 [0.76-1.34],0.9457171281854808
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Sleep apnoea,22918,184,0.98 [0.71-1.34],0.8911013825637837
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22694,469,1.25 [1.03-1.52],0.0222944680997209
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22343,118,0.95 [0.64-1.42],0.8081523825003551
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22445,220,1.26 [0.95-1.67],0.1021397831906
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23299,87,1.24 [0.80-1.94],0.3412276614920875
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Hemiplegia,23270,58,1.19 [0.70-2.03],0.5292802648441746
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Other neurological diseases,23139,122,1.30 [0.89-1.89],0.174509683239702
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23055,306,1.13 [0.89-1.44],0.305707461706346
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22924,175,1.03 [0.75-1.41],0.8758333127852514
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22828,79,1.46 [0.91-2.35],0.1148714772380048
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22853,104,0.94 [0.62-1.42],0.7547066161591326
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22799,50,1.10 [0.62-1.95],0.7539761842509088
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20647,143,1.04 [0.73-1.46],0.843924954983901
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20893,389,1.13 [0.91-1.39],0.265534309109553
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22673,250,1.17 [0.90-1.53],0.2383304785059468
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23242,70,2.29 [1.47-3.56],0.0002341018075216
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2594,70,2.36 [1.50-3.73],0.0002210214043376
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20718,70,2.35 [1.52-3.63],0.0001275186864945
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22992,97,1.04 [0.69-1.57],0.8603456981933093
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22947,52,1.18 [0.67-2.05],0.5699673905150348
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23098,78,0.98 [0.60-1.59],0.939556376791994
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23119,94,1.09 [0.70-1.69],0.6998611775393881
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23555,133,1.07 [0.74-1.53],0.732045880209504
AGER,Advanced glycosylation end product-specific receptor,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22705,94,0.94 [0.61-1.46],0.790780955330431
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15952,3744,1.26 [1.15-1.38],2.468382387773644e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22949,58,1.28 [0.74-2.21],0.37573807211363
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16841,2451,1.25 [1.13-1.38],1.7817124184479752e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertension,16887,2497,1.30 [1.18-1.44],2.294777112217055e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14500,110,8.49 [5.78-12.49],1.4731816711376954e-27
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20937,1666,1.41 [1.26-1.57],9.154772107161563e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Angina pectoris,20203,932,1.42 [1.23-1.63],1.585002262617015e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22217,333,1.68 [1.35-2.10],3.971080200922636e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22611,727,1.41 [1.21-1.65],1.2019313012886152e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23445,164,1.51 [1.10-2.07],0.0110224042125873
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19767,496,1.46 [1.20-1.77],0.0001170089319208
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20672,1425,1.40 [1.24-1.57],2.303674107988312e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22780,120,1.69 [1.16-2.46],0.0063002285010878
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22890,241,1.32 [1.01-1.73],0.0394122927146945
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22744,84,0.54 [0.34-0.87],0.0107688309307832
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22746,86,0.56 [0.35-0.90],0.0155256700927607
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14470,80,0.59 [0.36-0.96],0.0355335152546242
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18480,76,0.95 [0.57-1.58],0.8573122359713636
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Conduction disorders,18572,168,1.47 [1.06-2.05],0.0216522862353924
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11680,133,1.29 [0.88-1.90],0.1953028857293994
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12146,599,1.78 [1.49-2.14],5.988757197461744e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other arrhythmias,18488,84,1.74 [1.11-2.75],0.0162946530897021
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18530,126,1.94 [1.35-2.80],0.0003872927861084
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22343,312,1.42 [1.12-1.81],0.0034588059707825
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22615,183,1.58 [1.17-2.13],0.0027184996530023
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22643,165,1.67 [1.22-2.28],0.0012476308470944
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22730,146,1.62 [1.17-2.26],0.0041759917598594
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22251,89,1.77 [1.15-2.72],0.0096495400603795
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22307,145,1.26 [0.89-1.78],0.187750038715672
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22308,152,1.23 [0.87-1.72],0.2390439632046267
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22292,136,1.41 [0.99-2.01],0.0571219923473461
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23413,128,1.45 [1.01-2.08],0.0431086185660868
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Varicose veins,22495,339,1.13 [0.90-1.43],0.2851380578165798
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,Hypotension,22360,81,0.71 [0.44-1.14],0.1566165381083882
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18428,2005,0.89 [0.80-0.99],0.0247793485773381
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23477,88,0.92 [0.59-1.45],0.7321934009621895
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21519,253,1.00 [0.76-1.31],0.9843588183312344
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21481,215,1.11 [0.83-1.49],0.468683293555282
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22672,268,0.75 [0.57-0.97],0.0275227381338742
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22669,265,0.76 [0.58-0.98],0.0376277190132731
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22800,652,1.12 [0.95-1.33],0.1844968898336526
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic sinusitis,22221,73,0.90 [0.54-1.49],0.6840165411184654
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Nasal polyp,22312,164,0.91 [0.65-1.27],0.5640555008520021
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22576,428,1.16 [0.94-1.42],0.1714640786220418
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Deviated nasal septum,22373,225,1.08 [0.81-1.45],0.5883907563166816
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10243,61,0.82 [0.46-1.47],0.5134420693666596
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21130,854,0.67 [0.58-0.78],1.945433780259797e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Early onset COPD,22339,195,0.50 [0.37-0.68],1.2674384498409024e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22372,228,0.46 [0.35-0.61],1.1960396367873157e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22372,228,0.46 [0.35-0.61],1.1960396367873157e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22241,662,0.75 [0.63-0.88],0.0006741356834187
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Asthma,16062,662,0.75 [0.62-0.89],0.0011073263305691
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15714,662,0.75 [0.63-0.90],0.0017709658075053
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16052,652,0.74 [0.62-0.89],0.0011311401492992
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23219,98,0.39 [0.26-0.61],2.2498704057511345e-05
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Interstitial lung disease,22479,78,0.27 [0.16-0.43],6.186499823929404e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23303,78,0.26 [0.16-0.43],5.1418665966419364e-08
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22472,71,0.30 [0.18-0.50],3.398250835072613e-06
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Pleural effusion,21338,133,1.02 [0.70-1.48],0.9257994211008684
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other diseases of pleura,21487,282,0.87 [0.68-1.13],0.298278322384862
AGER,Advanced glycosylation end product-specific receptor,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22289,126,0.68 [0.46-0.99],0.0430083706589925
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15737,5600,1.06 [0.98-1.14],0.151260129760341
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23152,362,0.94 [0.75-1.18],0.6070388396842338
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23620,78,1.01 [0.61-1.68],0.9578457529788802
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Impacted teeth,23623,75,1.08 [0.65-1.80],0.7692135332161055
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Dental caries,22898,108,1.05 [0.69-1.58],0.8255834426242215
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22871,81,0.79 [0.49-1.28],0.3353161124765759
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23610,87,0.94 [0.58-1.53],0.8156660669453144
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22867,77,1.51 [0.94-2.42],0.0857186852793671
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22639,76,0.86 [0.53-1.42],0.5614251423748469
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23552,54,1.07 [0.60-1.91],0.8186503378784279
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18087,324,1.26 [1.00-1.60],0.0475901757787531
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19750,1987,1.13 [1.02-1.25],0.0192437527599886
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophagitis,18147,384,1.18 [0.95-1.46],0.1416986593379289
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18404,641,1.11 [0.94-1.32],0.2311832989123765
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17836,73,1.16 [0.71-1.90],0.5506109132459946
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18039,276,1.23 [0.95-1.58],0.1109860290196344
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17837,74,1.01 [0.62-1.65],0.952843303254342
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Gastric ulcer,17923,160,1.33 [0.96-1.84],0.0869419502084159
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Duodenal ulcer,17937,174,1.31 [0.96-1.79],0.0936492345186267
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23456,119,1.23 [0.84-1.79],0.284726015400222
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Chronic gastritis,17877,114,1.05 [0.71-1.55],0.8007549964738032
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18534,771,1.12 [0.96-1.31],0.1492099056413237
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of appendix,23490,108,0.82 [0.54-1.25],0.3565990192156204
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Functional dyspepsia,18053,290,1.10 [0.85-1.41],0.4747882234311978
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,17923,160,1.05 [0.75-1.46],0.775560569488762
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23445,171,1.09 [0.80-1.51],0.5794599212934286
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute appendicitis,23469,87,0.73 [0.45-1.17],0.1929906633172214
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Hernia,20156,2053,0.92 [0.83-1.01],0.0882956946482548
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Inguinal hernia,19234,1131,0.94 [0.82-1.07],0.3293352382842359
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Umbilical hernia,18289,186,0.55 [0.40-0.75],0.0001563627200962
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ventral hernia,18199,96,0.71 [0.46-1.09],0.120970903877081
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18869,766,0.99 [0.85-1.16],0.8957202279074323
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22785,603,1.35 [1.14-1.61],0.0006551033213173
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestines,18237,1817,1.10 [0.99-1.22],0.0748284049846937
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23309,56,1.51 [0.86-2.65],0.1554617880896853
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23573,72,1.41 [0.85-2.32],0.1793205642729728
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn disease,22254,72,1.43 [0.87-2.37],0.1625323640795536
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22239,57,1.33 [0.75-2.34],0.3278082204762395
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23519,144,1.16 [0.82-1.66],0.3998327401534786
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Ulcerative colitis,22326,144,1.19 [0.83-1.69],0.3510532543294345
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22312,130,1.15 [0.79-1.68],0.4588290408615534
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22636,454,1.34 [1.09-1.63],0.0044003245613396
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22633,451,1.36 [1.11-1.66],0.0027514364828485
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16513,93,1.00 [0.65-1.55],0.9911462240843968
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal stricture,23190,93,0.99 [0.64-1.54],0.979687550225213
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16486,66,1.06 [0.63-1.77],0.8329755466580581
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16964,544,1.07 [0.89-1.28],0.4999808675058406
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16506,86,1.15 [0.73-1.84],0.54490601402864
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16602,182,1.46 [1.08-1.99],0.0149662911566735
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Constipation,22083,166,1.43 [1.04-1.97],0.0290451002530034
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23260,53,0.74 [0.42-1.33],0.3177622389790472
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16582,162,1.03 [0.74-1.44],0.8518967761044337
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16518,98,0.92 [0.59-1.41],0.6876195508908257
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17285,865,0.99 [0.85-1.15],0.8837890274209255
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of intestine,16735,315,1.07 [0.84-1.36],0.5785026011831502
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23249,42,0.59 [0.31-1.14],0.1163285250400111
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of liver,22796,145,1.50 [1.07-2.10],0.0189925730319399
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of liver,22736,85,1.34 [0.86-2.09],0.1960502413401011
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22482,373,1.11 [0.89-1.38],0.3642842907200967
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholelithiasis,22377,268,1.05 [0.81-1.35],0.7371415309777728
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Cholecystitis,22177,68,1.09 [0.65-1.82],0.744615772247629
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22142,33,2.38 [1.22-4.63],0.0109969795760764
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis,22185,76,0.75 [0.46-1.23],0.2534961557410173
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23446,76,0.74 [0.46-1.21],0.2352016710369083
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22257,319,1.11 [0.88-1.41],0.3848878289898231
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21974,36,0.82 [0.40-1.68],0.5874506925834511
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Coeliac disease,21964,26,0.51 [0.22-1.19],0.1190967799547058
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21999,61,1.55 [0.92-2.63],0.101256785990715
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22166,228,1.03 [0.78-1.36],0.8203576137048202
AGER,Advanced glycosylation end product-specific receptor,Chapter XI Diseases of the digestive system,GI-bleeding,22162,224,1.04 [0.79-1.38],0.7812564902413344
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20495,1481,1.11 [0.99-1.24],0.0843288626635387
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23193,92,0.96 [0.62-1.49],0.8475042037888598
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23261,446,0.99 [0.81-1.21],0.9154431387149184
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22038,461,1.44 [1.18-1.75],0.0002618592876421
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22630,459,0.91 [0.74-1.11],0.3510711329113747
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22275,104,0.57 [0.38-0.88],0.0102290156173988
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22466,295,1.11 [0.87-1.43],0.3955097649588384
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23374,92,0.79 [0.51-1.23],0.3038118551245329
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23359,77,0.89 [0.55-1.44],0.6422276242964395
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23339,57,0.83 [0.47-1.44],0.5050156954739198
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23316,59,nan [nan-nan],
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23314,57,nan [nan-nan],
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22871,56,0.99 [0.56-1.76],0.970904763350924
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23178,363,0.98 [0.78-1.23],0.8748488746573547
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21659,82,0.95 [0.59-1.52],0.8218361279986028
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21623,46,1.92 [1.05-3.50],0.0333263753235758
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21618,41,1.87 [0.99-3.53],0.0524461923449189
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21761,184,1.42 [1.04-1.94],0.0264235379231264
AGER,Advanced glycosylation end product-specific receptor,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21739,162,1.34 [0.96-1.87],0.0836353201375839
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17443,3527,1.11 [1.02-1.20],0.0150676841512469
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18913,2073,1.14 [1.03-1.26],0.0104464762002982
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21417,1070,1.01 [0.89-1.16],0.8641258138489998
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16930,90,1.42 [0.92-2.20],0.1142244232511552
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17251,411,1.46 [1.19-1.79],0.0003436240847582
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23379,87,1.49 [0.97-2.30],0.0666938899548561
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23384,77,1.85 [1.19-2.89],0.0064375190627665
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17896,1056,1.12 [0.97-1.28],0.1206271549312152
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20320,1056,1.07 [0.94-1.23],0.3093374701615305
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16969,129,1.36 [0.94-1.97],0.100962354280527
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22678,125,1.40 [0.97-2.02],0.0757921341396488
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17005,165,1.70 [1.23-2.33],0.0011083047263386
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16895,55,1.48 [0.85-2.60],0.1669924517931518
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17092,252,1.04 [0.79-1.36],0.7924852189818331
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23518,121,1.05 [0.72-1.53],0.8113722940075551
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17409,569,1.15 [0.96-1.39],0.1282470239975884
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17141,301,1.22 [0.96-1.56],0.1097482596953581
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17982,1142,1.10 [0.96-1.26],0.1594191537797802
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16864,24,1.39 [0.60-3.21],0.4451107635850657
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16887,47,0.72 [0.39-1.34],0.2970928132639379
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16868,28,2.61 [1.32-5.14],0.0055555001265566
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16853,13,0.99 [0.30-3.25],0.9810506573454656
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17425,585,1.02 [0.85-1.23],0.7982860917360782
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17352,512,1.01 [0.83-1.24],0.8852123482557213
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19086,253,1.24 [0.95-1.62],0.1214918155763635
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23351,36,1.61 [0.81-3.19],0.1758582735820875
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23333,18,1.34 [0.51-3.48],0.554603979833543
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20675,44,1.65 [0.90-3.00],0.1030423395422078
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20915,284,1.27 [1.00-1.62],0.0546087449930402
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21447,816,1.16 [1.00-1.35],0.0539173180201812
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20791,160,1.18 [0.86-1.64],0.3051829640893018
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20724,93,1.40 [0.92-2.13],0.1161709216443036
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21262,631,1.16 [0.98-1.38],0.0854792448204706
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20681,50,0.59 [0.32-1.10],0.0989456178221885
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20855,224,1.24 [0.94-1.64],0.1344125733649199
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20727,96,0.91 [0.59-1.43],0.6918698357585908
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20695,64,0.82 [0.48-1.41],0.479803621383183
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20748,117,1.38 [0.95-2.02],0.0949468306782764
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20682,51,0.94 [0.52-1.69],0.8364059707516851
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20882,251,1.21 [0.93-1.58],0.1564509657566808
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20581,234,1.04 [0.78-1.37],0.8033792319566544
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20409,62,1.07 [0.62-1.84],0.8156605009015048
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20409,62,0.95 [0.56-1.62],0.8548894662604749
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20407,60,1.10 [0.63-1.92],0.7357600955778454
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20408,61,1.02 [0.58-1.78],0.95501697699373
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20520,173,0.87 [0.63-1.20],0.3853638081758043
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20509,162,0.91 [0.65-1.27],0.5722630067541609
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20597,250,1.03 [0.79-1.34],0.8345361152481895
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20397,50,1.05 [0.58-1.90],0.8678349648550023
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20433,86,1.04 [0.67-1.62],0.8618128448205096
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20460,113,0.72 [0.48-1.07],0.1058765596710962
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20389,42,0.80 [0.42-1.55],0.5127393714291608
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20689,342,1.11 [0.88-1.39],0.3746898932399538
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20488,141,1.07 [0.76-1.52],0.6934046383872703
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20530,183,1.21 [0.89-1.64],0.2190031136222439
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22615,104,0.82 [0.54-1.23],0.3358092702889025
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22802,291,1.20 [0.94-1.54],0.1413015200684399
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22569,58,0.97 [0.55-1.72],0.9281339063317182
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22560,49,1.42 [0.77-2.62],0.256202870523698
AGER,Advanced glycosylation end product-specific receptor,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22598,87,1.77 [1.14-2.75],0.0109413493452017
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18111,2362,1.58 [1.43-1.74],1.4743555298891174e-20
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20374,1280,1.23 [1.09-1.39],0.0007720832819524
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20831,305,4.99 [3.98-6.26],6.062515278771799e-44
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20619,93,2.73 [1.83-4.07],8.852814382278262e-07
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20863,72,3.87 [2.52-5.95],6.568787358356346e-10
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20881,90,,
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20884,93,6.96 [4.82-10.07],5.740008018255367e-25
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23146,360,1.25 [1.01-1.57],0.0446406949842303
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23099,79,4.07 [2.79-5.94],3.0754665418369094e-13
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23042,256,1.35 [1.05-1.76],0.0215596153995106
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22918,132,1.09 [0.75-1.57],0.6495102615729764
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21429,834,1.27 [1.10-1.48],0.0014607276498303
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Cystitis,20655,60,1.44 [0.84-2.44],0.1825435773211161
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20668,73,1.29 [0.79-2.11],0.3045760254370071
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20979,384,1.24 [1.00-1.54],0.0519510436440757
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20736,141,1.57 [1.11-2.22],0.0100724332732061
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20963,368,1.39 [1.12-1.73],0.0031860775689346
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19660,566,1.20 [1.00-1.44],0.0470371035897952
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19200,106,1.03 [0.68-1.55],0.8832489272870558
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Hydrocele,19195,101,1.23 [0.81-1.85],0.3310409381746757
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19255,161,1.60 [1.16-2.22],0.0043302954393444
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19257,163,1.26 [0.91-1.75],0.1625794330031779
AGER,Advanced glycosylation end product-specific receptor,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19310,216,1.15 [0.86-1.53],0.3404398531062484
AGER,Advanced glycosylation end product-specific receptor,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23135,79,1.44 [0.91-2.27],0.1208777525982187
AGER,Advanced glycosylation end product-specific receptor,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21472,546,0.82 [0.68-0.98],0.0328774690200698
